1-7 of 7
Haiying Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preliminary Results of a Phase Ⅱ Study of Lenalidomide Combined with Immunochemotherapy in Patients with Primary Central Nervous System Lymphoma

Shuna Yao, Zhihua Yao, Zheng Yan, Haiying Wang, Junfeng Chu, Shuang Zhao, Xinyang Zhao, Yanyan Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 1758.
https://doi.org/10.1182/blood-2023-189345
Published: 2023
Journal Articles

As Fast As We Can: Rational Design of Rapid Chimeric Antigen Receptor T Cell Manufacturing

Pengfei Jiang, Shih-Ting Cao, Haiying Wang, Qinghui Xiong, Mingyuan Gu, Chengbing Fu, Xiu Li, Mian Zhang, Na Li, Jing Li, Xin Xu, Yiwei Gong
Journal: Blood
Blood (2023) 142 (Supplement 1): 3453.
https://doi.org/10.1182/blood-2023-188144
Published: 2023
Journal Articles

Phase II Clinical Trial of R-CHOP Combined with Lenalidomide in the First-Line Treatment for Patients with High Risk Diffuse Large B Cell Lymphoma

Shuang Zhao, Jiuyang Zhang, Zheng Yan, Yuanlin Xu, Zhihua Yao, Junfeng Chu, Shuna Yao, Haiying Wang, Wenping Zhou, Xufeng Luo, Peipei Zhang, Yanyan Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6237.
https://doi.org/10.1182/blood-2023-185955
Published: 2023
Journal Articles

Selective PI3Kδ Inhibitor Parsaclisib Combined with HDAC Inhibitor Chidamide in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma: Preliminary Results of a Phase Ib/Ⅱ Study

Zheng Yan, Shuna Yao, Shuang Zhao, Haiying Wang, Junfeng Chu, Yuanlin Xu, Jiuyang Zhang, Lina Zhang, Quande Lin, Lijie Liang, Ping Wang, Wenyong Li, Xiaolu Teng, Zhihua Yao, Yanyan Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3075.
https://doi.org/10.1182/blood-2023-185902
Published: 2023
Journal Articles

Preliminary Results of a Phase Ⅱ Study of Zanubrutinib Combined with Immunochemotherapy in Patients with CD79A/CD79B-Mutant Diffuse Large B-Cell Lymphoma

Zhihua Yao, Zheng Yan, Shuna Yao, Haiying Wang, Junfeng Chu, Shuang Zhao, Jie Ma, Bing Wei, Jiawen Zheng, Quande Lin, Zheng Xu, Xinyang Zhao, Yanyan Liu
Journal: Blood
Blood (2022) 140 (Supplement 1): 3767–3768.
https://doi.org/10.1182/blood-2022-165944
Published: 2022
Journal Articles

Phase II Clinical Trial of Camrelizumab Combined with AVD (Epirubicin, Vincristine and Dacarbazine) in the First-Line Treatment for Patients with Advanced Classical Hodgkin's Lymphoma

Shuang Zhao, Yanyan Liu, Zhihua Yao, Zheng Yan, Shuna Yao, Junfeng Chu, Haiying Wang, Jiuyang Zhang, Peipei Zhang, Wenping Zhou
Journal: Blood
Blood (2022) 140 (Supplement 1): 6579–6580.
https://doi.org/10.1182/blood-2022-166829
Published: 2022
Journal Articles

Tyrosine kinase inhibitors induce mesenchymal stem cell–mediated resistance in BCR-ABL + acute lymphoblastic leukemia

Brief Report
Saradhi Mallampati, Xiaohong Leng, Haiqing Ma, Jianfang Zeng, June Li, Haiying Wang, Kevin Lin, Yue Lu, Yang Yang, Baohua Sun, Yun Gong, Ju-Seog Lee, Marina Konopleva, Michael Andreeff, Ralph B. Arlinghaus, Zhen Cai, Bingliang Fang, Haifa Shen, Xin Han, Cheryl F. Hirsch-Ginsberg, Xiaolian Gao, Anurag N. Paranjape, Sendurai A. Mani, Karen Clise-Dwyer, Xiaoping Sun
Journal: Blood
Blood (2015) 125 (19): 2968–2973.
https://doi.org/10.1182/blood-2014-05-576421
Published: 2015
Includes: Supplemental data